CLL is the most prevalent leukemia in adults and it is not considered curable without an allogeneic (donor) stem cell transplant. However, advances in therapy have been made, notably the emergence of kinase inhibitors for patients whose disease relapsed, according to the study background…
Centralized breast cancer care at CBCs can lead to more timely breast reconstruction for women undergoing breast cancer surgery, suggests the study by ASPS Member Surgeon Albert H. Chao, MD, and colleagues of The Ohio State University, Columbus. They write, “Access to breast reconstruction at our institution improved significantly after our CBC opened, with significant increases in internal referral rates and immediate reconstruction rates.” Transition to CBC Improves Processes of Care The researchers assessed “process of care” outcomes related to breast reconstruction before and after their hospital transitioned to a CBC approach. Comprehensive breast centers seek to improve patient care and outcomes by assembling a group of highly specialized practitioners — oncologists, plastic and reconstructive surgeons, and other professionals — to provide coordinated breast cancer care…
Centralized breast cancer care at CBCs can lead to more timely breast reconstruction for women undergoing breast cancer surgery, suggests the study by ASPS Member Surgeon Albert H. Chao, MD, and colleagues of The Ohio State University, Columbus. …
Dr. Julia White of Ohio State’s Comprehensive Cancer Center — James Cancer Hospital and Solove Research Institute has helped develop a modified treatment board that allows patients to lie comfortably on their stomachs while the breast tissue falls away from the chest wall, allowing the radiation to target the cancer. Traditionally, women who undergo radiation therapy lie on their backs in the supine position. …
A new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) shows that a molecule called nuclear factor kappa B (NF-kB) helps cancer cells by suppressing the immune system’s ability to detect and destroy them. …
The researchers modified a type of human immune cell — called T lymphocytes, or T cells — to target a molecule called CS1, which is found on more than 95 percent of myeloma cells, and to kill the cells. The researchers grew the modified cells in the lab to increase their numbers and then injected them into an animal model where they again killed human myeloma cells. The findings were published in the journal Clinical Cancer Research…
source : http://www.sciencedaily.com/releases/2014/05/140531090722.htm
source : http://www.sciencedaily.com/releases/2014/03/140320121912.htm
source : http://www.sciencedaily.com/releases/2014/02/140226174437.htm
source : http://www.sciencedaily.com/releases/2014/02/140204123615.htm